Click here to BLOCK YOUR CONTENT SPACE IN OUR NEXT ISSUES
Latest News
UK Life Sciences Manufacturing To Get Aided With £277m Funds
The Life Sciences Innovative Manufacturing Fund grant is a combination of government funding as well as funding through an additional private investment.
Cancer Drugs Info Full of Gaps - Regulatory Action Needed
Latest study findings report that there is a sizable gap between the information provided pertaining to benefits and flaws of oncology drugs across Europe.
Immunotherapy Efficacy Shown Through New Delivery Approach
Intrathecal, intravenous nivolumab immunotherapy are considered as safe and also enhanced survival of subset of melanoma patient having leptomeningeal disease.
EMA Releases Mid-Point Regulatory Science Strategy Study
To advance regulatory science, European Medicines Agency has come up with 5-year goal through a report that summarizes its regulatory science strategy by 2025.
Prediction of Enzyme by AI Functions Better Than Key Tools
The functionalities of enzymes on the basis of the amino acid sequences can help in their better forecast because of a novel artificial intelligence tool.
New Antibiotic Discovery Helped By Australia Sepsis Study
Sepsis which is the cause of 20% of deaths in the world has now got a new antibiotic thanks to the research done in Australia by the University of Queensland.
Monoclonal Antibodies Help COVID-19 Hospitalisation To Dip
Risk of hospitalisation and even death in case of COVID-19 patients has been demonstrated to dip by the usage of monoclonal antibodies due to their efficacy.
Galapagos, NovAliX Enter Integrated Drug Discovery Collaboration
Galapagos NV entered into a strategic collaboration with NovAliX in which Galapagos’ research and discovery capabilities and exclusively related employees based in Romainville, France.
eConsent Trial To Enable Making Patient Partaking Seamless
eConsent which has been introduced in the Netherlands for the first time will enable in making entire process of research participation of patients seamless.